IBDEI1PL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30280,1,4,0)
 ;;=4^O36.0120
 ;;^UTILITY(U,$J,358.3,30280,2)
 ;;=^5016849
 ;;^UTILITY(U,$J,358.3,30281,0)
 ;;=O36.0121^^178^1916^50
 ;;^UTILITY(U,$J,358.3,30281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30281,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, second tri, fetus 1
 ;;^UTILITY(U,$J,358.3,30281,1,4,0)
 ;;=4^O36.0121
 ;;^UTILITY(U,$J,358.3,30281,2)
 ;;=^5016850
 ;;^UTILITY(U,$J,358.3,30282,0)
 ;;=O36.0122^^178^1916^51
 ;;^UTILITY(U,$J,358.3,30282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30282,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, second tri, fetus 2
 ;;^UTILITY(U,$J,358.3,30282,1,4,0)
 ;;=4^O36.0122
 ;;^UTILITY(U,$J,358.3,30282,2)
 ;;=^5016851
 ;;^UTILITY(U,$J,358.3,30283,0)
 ;;=O36.0123^^178^1916^52
 ;;^UTILITY(U,$J,358.3,30283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30283,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, second tri, fetus 3
 ;;^UTILITY(U,$J,358.3,30283,1,4,0)
 ;;=4^O36.0123
 ;;^UTILITY(U,$J,358.3,30283,2)
 ;;=^5016852
 ;;^UTILITY(U,$J,358.3,30284,0)
 ;;=O36.0124^^178^1916^53
 ;;^UTILITY(U,$J,358.3,30284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30284,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, second tri, fetus 4
 ;;^UTILITY(U,$J,358.3,30284,1,4,0)
 ;;=4^O36.0124
 ;;^UTILITY(U,$J,358.3,30284,2)
 ;;=^5016853
 ;;^UTILITY(U,$J,358.3,30285,0)
 ;;=O36.0125^^178^1916^54
 ;;^UTILITY(U,$J,358.3,30285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30285,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, second tri, fetus 5
 ;;^UTILITY(U,$J,358.3,30285,1,4,0)
 ;;=4^O36.0125
 ;;^UTILITY(U,$J,358.3,30285,2)
 ;;=^5016854
 ;;^UTILITY(U,$J,358.3,30286,0)
 ;;=O36.0130^^178^1916^55
 ;;^UTILITY(U,$J,358.3,30286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30286,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, third trimester, unsp
 ;;^UTILITY(U,$J,358.3,30286,1,4,0)
 ;;=4^O36.0130
 ;;^UTILITY(U,$J,358.3,30286,2)
 ;;=^5016856
 ;;^UTILITY(U,$J,358.3,30287,0)
 ;;=O36.0131^^178^1916^56
 ;;^UTILITY(U,$J,358.3,30287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30287,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, third tri, fetus 1
 ;;^UTILITY(U,$J,358.3,30287,1,4,0)
 ;;=4^O36.0131
 ;;^UTILITY(U,$J,358.3,30287,2)
 ;;=^5016857
 ;;^UTILITY(U,$J,358.3,30288,0)
 ;;=O36.0132^^178^1916^57
 ;;^UTILITY(U,$J,358.3,30288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30288,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, third tri, fetus 2
 ;;^UTILITY(U,$J,358.3,30288,1,4,0)
 ;;=4^O36.0132
 ;;^UTILITY(U,$J,358.3,30288,2)
 ;;=^5016858
 ;;^UTILITY(U,$J,358.3,30289,0)
 ;;=O36.0133^^178^1916^58
 ;;^UTILITY(U,$J,358.3,30289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30289,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, third tri, fetus 3
 ;;^UTILITY(U,$J,358.3,30289,1,4,0)
 ;;=4^O36.0133
 ;;^UTILITY(U,$J,358.3,30289,2)
 ;;=^5016859
 ;;^UTILITY(U,$J,358.3,30290,0)
 ;;=O36.0134^^178^1916^59
 ;;^UTILITY(U,$J,358.3,30290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30290,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, third tri, fetus 4
 ;;^UTILITY(U,$J,358.3,30290,1,4,0)
 ;;=4^O36.0134
 ;;^UTILITY(U,$J,358.3,30290,2)
 ;;=^5016860
 ;;^UTILITY(U,$J,358.3,30291,0)
 ;;=O36.0135^^178^1916^60
 ;;^UTILITY(U,$J,358.3,30291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30291,1,3,0)
 ;;=3^Maternal care for anti-D antibodies, third tri, fetus 5
 ;;^UTILITY(U,$J,358.3,30291,1,4,0)
 ;;=4^O36.0135
 ;;^UTILITY(U,$J,358.3,30291,2)
 ;;=^5016861
 ;;^UTILITY(U,$J,358.3,30292,0)
 ;;=O36.0910^^178^1916^182
 ;;^UTILITY(U,$J,358.3,30292,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI1PL
